Regulus Therapeutics
RGLS
#7157
Rank
NZ$0.97 B
Marketcap
NZ$14.09
Share price
0.00%
Change (1 day)
458.98%
Change (1 year)

Regulus Therapeutics (RGLS) - Total assets

Total assets on the balance sheet as of March 2025 : NZ$0.12 Billion

According to Regulus Therapeutics's latest financial reports the company's total assets are NZ$0.12 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.14 B206.98%
2023-12-31NZ$48.62 M-33.92%
2022-12-31NZ$73.58 M-26.58%
2021-12-31NZ$0.10 B92.3%
2020-12-31NZ$52.11 M-16.59%
2019-12-31NZ$62.48 M50.08%
2018-12-31NZ$41.63 M-62%
2017-12-31NZ$0.10 B-24.61%
2016-12-31NZ$0.14 B-29.5%
2015-12-31NZ$0.20 B-5.81%
2014-12-31NZ$0.21 B46.14%
2013-12-31NZ$0.14 B19.01%
2012-12-31NZ$0.12 B129.03%
2011-12-31NZ$54.94 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sanofi
SNY
NZ$255.88 B 197,930.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$50.91 B 39,302.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$149.33 B 115,469.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$196.89 B 152,273.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$143.78 B 111,170.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
NZ$0.15 B 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$8.85 B 6,755.30%๐Ÿ‡บ๐Ÿ‡ธ USA